Baker Brothers Advisors - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 203 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$8,660,750
+19.7%
343,0000.0%0.05%
+19.0%
Q2 2023$7,237,300
+23.8%
343,0000.0%0.04%
+31.2%
Q1 2023$5,848,150
+1367.2%
343,000
+1619.3%
0.03%
+1500.0%
Q4 2022$398,601
-7.3%
19,9500.0%0.00%
-33.3%
Q3 2022$430,000
-99.0%
19,950
-99.1%
0.00%
-98.8%
Q2 2022$42,516,000
-16.1%
2,156,0010.0%0.24%
-17.2%
Q1 2022$50,666,000
-13.7%
2,156,0010.0%0.29%
+1.7%
Q4 2021$58,729,000
-1.1%
2,156,0010.0%0.29%
+9.6%
Q3 2021$59,376,000
-3.2%
2,156,0010.0%0.26%
-3.0%
Q2 2021$61,360,000
-16.4%
2,156,0010.0%0.27%
-15.4%
Q1 2021$73,433,000
+2.3%
2,156,0010.0%0.32%
+17.8%
Q4 2020$71,773,000
-1.7%
2,156,001
-5.1%
0.27%
-7.5%
Q3 2020$73,045,000
-12.3%
2,272,712
-24.9%
0.29%
-20.7%
Q2 2020$83,319,000
+71.8%
3,025,3840.0%0.37%
+23.1%
Q1 2020$48,497,000
-16.9%
3,025,384
+23.7%
0.30%
-3.5%
Q4 2019$58,393,000
+48.5%
2,445,265
+9.7%
0.31%
+15.7%
Q3 2019$39,333,000
-37.6%
2,229,760
-9.4%
0.27%
-37.4%
Q2 2019$63,033,000
+4.4%
2,462,216
+18.5%
0.43%
+10.6%
Q1 2019$60,396,000
+148.6%
2,077,601
+12.2%
0.39%
+94.5%
Q4 2018$24,298,000
-35.1%
1,851,9820.0%0.20%
-19.4%
Q3 2018$37,447,000
+126.2%
1,851,982
+164.6%
0.25%
+99.2%
Q2 2018$16,555,000
+5.0%
700,0000.0%0.12%
-7.5%
Q1 2018$15,764,000
-27.8%
700,0000.0%0.13%
-29.1%
Q4 2017$21,826,000
-0.1%
700,0000.0%0.19%
+6.8%
Q3 2017$21,847,000
+218.3%
700,000
+75.0%
0.18%
+195.0%
Q2 2017$6,864,000
-2.0%
400,0000.0%0.06%
+5.3%
Q1 2017$7,004,000
+32.4%
400,0000.0%0.06%
+9.6%
Q4 2016$5,292,000
-8.9%
400,0000.0%0.05%
-1.9%
Q3 2016$5,808,000
-60.7%
400,000
-73.3%
0.05%
-65.8%
Q2 2016$14,790,000
-22.2%
1,500,0000.0%0.16%
-22.5%
Q1 2016$19,005,000
+4.7%
1,500,000
+50.0%
0.20%
+33.3%
Q4 2015$18,150,000
-38.3%
1,000,000
-36.8%
0.15%
-44.9%
Q3 2015$29,405,000
-24.0%
1,583,4900.0%0.27%
-19.8%
Q2 2015$38,669,000
+17.4%
1,583,4900.0%0.34%
+23.7%
Q1 2015$32,937,000
+92.2%
1,583,490
+42.9%
0.27%
+56.6%
Q4 2014$17,138,000
+18.5%
1,107,8500.0%0.18%
-3.8%
Q3 2014$14,457,000
+138.0%
1,107,850
+264.4%
0.18%
+145.9%
Q2 2014$6,075,000
-42.4%
304,050
-45.1%
0.07%
-44.8%
Q1 2014$10,549,000
-22.1%
554,050
-30.4%
0.13%
-29.8%
Q4 2013$13,538,000
-8.3%
796,378
-15.8%
0.19%
-9.0%
Q3 2013$14,764,000
+55.1%
945,803
+18.8%
0.21%
+11.7%
Q2 2013$9,518,000795,8030.19%
Other shareholders
INSMED INC shareholders Q2 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,889,491$148,709,64814.07%
Deep Track Capital, LP 6,000,000$151,500,0005.85%
Octagon Capital Advisors LP 1,284,000$32,421,0004.98%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,446,334$87,019,9344.70%
MPM BioImpact LLC 527,458$13,318,3153.56%
Novo Holdings A/S 1,339,304$33,817,4262.50%
Bleichroeder LP 325,000$8,206,2502.02%
GREAT POINT PARTNERS LLC 394,872$9,970,5181.82%
Endurant Capital Management LP 79,471$2,006,6431.80%
SECTORAL ASSET MANAGEMENT INC 347,392$8,771,6481.71%
View complete list of INSMED INC shareholders